Voluntary Wheel Running Mitigates Disease in an Orai1 Gain-of-Function Mouse Model of Tubular Aggregate Myopathy
Cells · 2025
DOI: 10.3390/cells14171383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Thomas N O'Connor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Genomics Graduate Program, Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: ORAI1 Protein, Myopathies, Structural, Congenital, Physical Conditioning, Animal, Gain of Function Mutation. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Telethon ONLUS, National Institute of Health.
Abstract (Originalsprache)
Tubular aggregate myopathy (TAM) is an inherited skeletal muscle disease associated with progressive muscle weakness, cramps, and myalgia. Tubular aggregates (TAs) are regular arrays of highly ordered and densely packed straight-tubules observed in muscle biopsies; the extensive presence of TAs represent a key histopathological hallmark of this disease in TAM patients. TAM is caused by gain-of-function mutations in proteins that coordinate store-operated Ca2+ entry (SOCE): STIM1 Ca2+ sensor proteins in the sarcoplasmic reticulum (SR) and Ca2+-permeable ORAI1 channels in the surface membrane. Here, we assessed the therapeutic potential of endurance exercise in the form of voluntary wheel running (VWR) in mitigating TAs and muscle weakness in Orai1G100S/+ (GS) mice harboring a gain-of-function mutation in the ORAI1 pore. Six months of VWR exercise significantly increased specific force production, upregulated biosynthetic and protein translation pathways, and normalized both mitochondrial protein expression and morphology in the soleus of GS mice. VWR also restored Ca2+ store content, reduced the incidence of TAs, and normalized pathways involving the formation of supramolecular complexes in fast twitch muscles of GS mice. In summary, sustained voluntary endurance exercise improved multiple skeletal muscle phenotypes observed in the GS mouse model of TAM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics and Genomics Graduate Program, Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Department of Biology, Biological Sciences, University of Rochester, Rochester, NY 14642, USA.
- Center for Advanced Studies and Technology (CAST), University G. d'Annunzio of Chieti-Pescara, I-66100 Chieti, Italy.
- Department of Medicine and Aging Sciences (DMSI), University G. d'Annunzio of Chieti-Pescara, I-66100 Chieti, Italy.
ORCID-Profile: Thomas N O'Connor, Alice Brasile, Laura Pietrangelo, Chen Liang, Robert T Dirksen
Förderung
- NIAMS NIH HHS
- Telethon ONLUS
- National Institute of Health
- NIH MDA
- NIH
- MDA
Zitieren
APA
O'Connor, T. N., Zhao, N., Orciuoli, H. M., Malik, S., Brasile, A., Pietrangelo, L., He, M., Groom, L., Leigh, J., Mahamed, Z., Liang, C., Protasi, F., & Dirksen, R. T. (2025). Voluntary Wheel Running Mitigates Disease in an Orai1 Gain-of-Function Mouse Model of Tubular Aggregate Myopathy. Cells. https://doi.org/10.3390/cells14171383
Vancouver
O'Connor TN, Zhao N, Orciuoli HM, Malik S, Brasile A, Pietrangelo L, et al. Voluntary Wheel Running Mitigates Disease in an Orai1 Gain-of-Function Mouse Model of Tubular Aggregate Myopathy. Cells. 2025. doi:10.3390/cells14171383
BibTeX
@article{OConnor2025,
author = {O'Connor, Thomas N and Zhao, Nan and Orciuoli, Haley M and Malik, Sundeep and Brasile, Alice and Pietrangelo, Laura and He, Miao and Groom, Linda and Leigh, Jennifer and Mahamed, Zahra and Liang, Chen and Protasi, Feliciano and Dirksen, Robert T},
title = {Voluntary Wheel Running Mitigates Disease in an Orai1 Gain-of-Function Mouse Model of Tubular Aggregate Myopathy},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14171383}
}
EUVIMED